SCHEMBL19344049

SCHEMBL19344049

CC(C)(C)OC(=O)N1CCCC2(CCCN2C[C@H]2O[C@@H](n3ccc4c(Cl)ncnc43)[C@@H]3OC(C)(C)O[C@@H]32)C1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ PRMT5 O14744 10/20 0.46
▸ WDR77 Q9BQA1 7/20 0.46
▸ PI4KA P42356 1/20 0.35
▸ PI4K2B Q8TCG2 1/20 0.35
▸ PI4K2A Q9BTU6 1/20 0.35
▸ PI4KB Q9UBF8 1/20 0.35
▸ RXFP1 Q9HBX9 1/20 0.33
▸ ADORA1 P30542 1/20 0.33
▸ P2RX1 P51575 1/20 0.33
▸ P2RX3 P56373 1/20 0.33
▸ P2RX4 Q99571 1/20 0.33
▸ GPR119 Q8TDV5 1/20 0.32
▸ MMP2 P08253 1/20 0.32
▸ MMP13 P45452 1/20 0.32
▸ MMP14 P50281 1/20 0.32
▸ ADAM17 P78536 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19344047 0.95 PRMT5 (0.48) PRMT5WDR77PI4KAPI4K2BPI4K2A
SCHEMBL19344405 0.94 PRMT5 (0.49) PRMT5WDR77PI4KAPI4K2BPI4K2A
SCHEMBL19344252 0.92 PRMT5 (0.47) PRMT5WDR77PI4KAPI4K2BPI4K2A
SCHEMBL19344270 0.92 PRMT5 (0.54) PRMT5WDR77PI4KAPI4K2BPI4K2A
SCHEMBL19344250 0.91 PRMT5 (0.44) PRMT5WDR77PI4KAPI4K2BPI4K2A
SCHEMBL22434985 0.89 PRMT5 (0.39) PRMT5WDR77PI4KAPI4K2BPI4K2A
SCHEMBL19344045 0.88 PRMT5 (0.36) PRMT5WDR77PI4KAPI4K2BPI4K2A
SCHEMBL19344035 0.87 PRMT5 (0.39) PRMT5WDR77PI4KAPI4K2BPI4K2A
SCHEMBL19344126 0.87 PRMT5 (0.57) PRMT5WDR77PI4KAPI4K2BPI4K2A
SCHEMBL19343848 0.87 EIF2AK4 (0.37) PRMT5WDR77PI4KAPI4K2BPI4K2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3426664-B1 SUBSTITUTED NUCLEOSIDE ANALOGUES FOR USE AS PRMT5 INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2021-06-30 — — EP disclosed
WO-2017153186-A1 SUBSTITUTED NUCLEOSIDE ANALOGUES FOR USE AS PRMT5 INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2017-09-14 — — WO disclosed
Send feedback